Alembic Pharma has announced its third quarter results. Pranav Amin, director of Alembic Pharma says, the revenues have gone up 15% to Rs 383 crore from Rs 332 crore last year.
He further says, the company so far has filed 41 abbreviated new drug applications (ANDAs).Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
